<p>In paediatric oncology, imaging biomarkers play an increasing role in diagnostic imaging and research. They can be used for prediction, detection, staging, and grading of diseases, as well as for assessment of response to treatment. Imaging biomarkers are complementary to tissue-based biomarkers, enabling a more personalised approach in oncology care. In this white paper by the European Society of Paediatric Radiology (ESPR) Oncology Taskforce and European Association of Nuclear Medicine (EANM) Paediatrics Committee, an overview is given of the current knowledge on the use of imaging biomarkers in general and per tumour group.</p> Graphical Abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

White paper on the current state of imaging biomarkers in paediatric oncology

  • Rutger A.J. Nievelstein,
  • Lise Borgwardt,
  • Emilio J. Inarejos Clemente,
  • Thekla Von Kalle,
  • Martin Kyncl,
  • Maarten H. Lequin,
  • Annemieke S. Littooij,
  • Erika Pace,
  • Pier L. Di Paolo,
  • Rick R. Van Rijn,
  • Julian M.M. Rogasch,
  • Jurgen Schäfer,
  • Irmina Sefic Pasic,
  • Anita Spezzacatene,
  • Nelleke Tolboom,
  • Simon M. Wan,
  • Pietro Zucchetta

摘要

In paediatric oncology, imaging biomarkers play an increasing role in diagnostic imaging and research. They can be used for prediction, detection, staging, and grading of diseases, as well as for assessment of response to treatment. Imaging biomarkers are complementary to tissue-based biomarkers, enabling a more personalised approach in oncology care. In this white paper by the European Society of Paediatric Radiology (ESPR) Oncology Taskforce and European Association of Nuclear Medicine (EANM) Paediatrics Committee, an overview is given of the current knowledge on the use of imaging biomarkers in general and per tumour group.

Graphical Abstract